This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Boehringer Ingelheim Rcv Gmbh & Co. Kg, Sandoz Ag. Active years: 2017.
Company Filing History:
1 out of 19 
1 out of 149 
Years Active: 2017
Title: Innovations of Alexander Wittwer
Introduction
Alexander Wittwer is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of biotechnology, particularly in the area of transcription termination signal sequences. His work has implications for genetic research and applications in various biotechnological processes.
Latest Patents
Wittwer holds a patent for "Transcription terminator sequences." This invention provides new transcription termination signal sequences, especially a polynucleotide comprising at least two consecutive transcription termination signals. The invention is characterized by the fact that consecutive transcription termination signals comprise at least a first and a second transcription termination signal that are at most 1000 nucleotides apart. Additionally, at least one of the termination signals has or encodes an RNA hairpin structure. This patent showcases his innovative approach to genetic engineering.
Career Highlights
Throughout his career, Alexander Wittwer has worked with prominent companies in the pharmaceutical and biotechnology sectors. Notably, he has been associated with Sandoz AG and Boehringer Ingelheim RCV GmbH & Co. KG. His experience in these organizations has allowed him to apply his inventive skills in practical settings, contributing to advancements in the industry.
Collaborations
Wittwer has collaborated with various professionals in his field, including Gerald Striedner. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective projects.
Conclusion
Alexander Wittwer's contributions to the field of biotechnology, particularly through his patent on transcription terminator sequences, highlight his role as an influential inventor. His work continues to impact genetic research and biotechnological applications.